JiangFeng

Yuyao, China Founded: 2011 • Age: 15 yrs
Digital pathology systems are developed for image analysis and diagnosis.

About JiangFeng

JiangFeng is a company based in Yuyao (China) founded in 2011. JiangFeng has raised $28.98 million across 2 funding rounds from investors including Wisdomont Capital, Haoyue Capital and 铢杏谷 (Ginkgo Valley). JiangFeng operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, SpectraWAVE, IBA and Ionpath, among others.

  • Headquarter Yuyao, China
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website kfbio.cn
Key Metrics
  • Total Equity Funding
    $28.98M (USD)

    in 2 rounds

  • Latest Funding Round
    $14.89M (USD), Series C

    Jul 2022

  • Investors

Funding Insights of JiangFeng

JiangFeng has successfully raised a total of $28.98M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $14.89 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $28.98M
  • Total Rounds 2
  • Last Round Series C β€” $14.89M
  • First Round $14.09M

    (Apr 2020)

  • Investors Count 5

All 2 funding rounds of JiangFeng with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2022$14.89MSeries C–Shengshan Capital
Apr 2020$14.09MSeries B–Intel Capital
Valuation history

5 investors in total: 5 institutional.

Investors in JiangFeng

JiangFeng has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Wisdomont Capital, Haoyue Capital and 铢杏谷 (Ginkgo Valley).

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Wisdomont Capital is involved in capital management activities.
–wisdomont.com-
Investment in technology and support for young entrepreneurs are provided by Ginkgo Valley.
–yxgzb.comHangzhou, China
Investment in technology startups focusing on compute, AI, and related innovations.
–intelcapital.com-
-
–zjxgxtz.com-
Investment services in healthcare are provided by Haoyue Capital.
–healthcarecapital.com.cnShanghai, China
Premium access

Investor details for JiangFeng

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of JiangFeng

6 people are tracked at JiangFeng (4 in leadership, 2 in team).

NameRoleGroup
Henry Liu
National Sales DirectorLeadership
Liu Bingxian
chairman and general managerLeadership
Zheng Liu
Director Of Marketing & Business DevelopmentLeadership
Jane Zhu
Director For Asia Pacific Region(with Middle East)Leadership
Yuan Yao
Marketing StaffTeam
Tiki Shi
Overseas ManagerTeam
Premium access

Complete people profiles for JiangFeng

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of JiangFeng

3 dated milestones of JiangFeng across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded JiangFeng is founded.
  2. Funding First funding round of $14.1M.
  3. Funding Latest funding round, Series C, of $14.9M.

Competitors of JiangFeng

JiangFeng operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, SpectraWAVE, IBA and Ionpath, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
oxinst.com1959Abingdon, United Kingdom–2,027
Technology tools and systems for molecular scale are developed.
leica-microsystems.com1914Wetzlar, Germany–67
Imaging solutions for macro, micro, and nano structures are provided.
spectrawave.com2012Waltham, United States$79.88M36
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
iba-worldwide.com1986–$27.32M–
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
ionpath.com2014Menlo Park, United States$18M37
Multiplexed ion beam imaging platform for tissue biopsies is developed.
invenio-imaging.com2012Santa Clara, United States$7.5M–
Provider of a tissue imagine software and hardware solution for research diagnosis
lynceantech.com2002Fremont, United States$26.91M39
Delivers advanced imaging systems using local synchrotron x-ray sources for scientific and industrial applications.
siriusxt.com2015Dublin, Ireland$3.33M–
X-ray technology is used for 3D imaging of biological cells.
chromacitylasers.com2013Edinburgh, United Kingdom$4.93M12
Tunable fiber lasers are provided for industrial and scientific applications.
Premium access

Detailed competitors of JiangFeng

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Jiangfeng

Premium access

Complete news archive for JiangFeng

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to JiangFeng

10 companies that operate in the same segment as JiangFeng (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about JiangFeng

JiangFeng was founded in 2011 and raised its 1st funding round 9 years after it was founded.

JiangFeng is headquartered in Yuyao, China. It is registered at Yuyao, Zhejiang, China.

JiangFeng is a funded company, having raised a total of $28.98M across 2 funding rounds to date. The company's 1st funding round was a Series B of $14.09M, raised on Apr 2020.

JiangFeng was established in 2011 in Yuyao, China, focusing on digital pathology systems within the healthcare technology sector. A digital pathology image database is provided to support pathological analysis and diagnosis. Integration of modern medicine with automatic control technology, medical image processing, and computer network technology is utilized to facilitate remote sharing of pathological diagnosis information across operations.

JiangFeng's top competitors include Oxford Instruments, Leica Microsystems and IBA.

JiangFeng has 5 investors. Key investors include Wisdomont Capital, Haoyue Capital, 铢杏谷 (Ginkgo Valley), Intel Capital, and Zhejiang Shinkansen Media Investment.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available